Israel Says Pfizer (PFE) Vaccine Only 39% Effective in Preventing Delta Variant Infection

July 23, 2021 8:28 AM EDT
Get Alerts PFE Hot Sheet
Price: $43.89 -1.3%

Rating Summary:
    13 Buy, 19 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Bloomberg reports that according to most recent data from Israel’s Ministry of Health, Pfizer’s (NYSE: PFE) COVID-19 vaccine was only 39% effective in preventing infections from the Delta strain of the coronavirus.

Among those infected, the vaccine still offered 88% protection from hospitalizations and 91.4% from getting severely ill, based on the agency’s study of unspecified number of cases between June 20th and July 17th.

Earlier today, Pfizer (PFE) and BioNTech (NASDAQ: BNTX) announced another US Government order for additional 200M doses to be delivered between October 2021 and April 2022.

Shares of Pfizer remain mostly flat in the pre-market.

Written by Vlad Schepkov |

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, FDA, Trader Talk

Related Entities

Vlad Schepkov